(secondQuint)Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia.

 A phase III, multicenter, double-blind, comparative, parallel, randomized study.

 Enrollment will include adult and pediatric patients.

 The adult population is sized to test for non-inferiority.

 For the pediatric population, descriptive analyses are planned.

.

 Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia@highlight

The purpose of this study is to determine the efficacy and safety of micafungin (FK463) versus liposomal amphotericin B (AmBisome) in treating neutropenic and non-neutropenic patients with confirmed invasive candidiasis or candidemia.

 Enrollment will include adult and pediatric patients.

